Seven 23andMe Directors Resign: How Directors Can Avoid A Similar Fate
Facing on impasse on how to proceed with the struggling company, all seven independent directors at 23andMe resigned. Here’s what corporate board members should know.
Facing on impasse on how to proceed with the struggling company, all seven independent directors at 23andMe resigned. Here’s what corporate board members should know.
Chief executives at retail and consumer companies may have a shorter timeline to jumpstart sluggish performance.
As more companies announce that they are eliminating DEI initiatives, corporate boards need to consider how they will approach this matter.
In the face of poor performance, most boards will not get a lengthy grace period to devise and implement a turnaround plan. Some considerations for a proactive response.
Unsurprisingly, shareholder activism has increased this year. Here’s how corporate boards can avoid becoming targets.
Elon Musk’s recent bid for the Tesla board to invest in his new AI startup leads to questions about where boards should draw the line.